-- 据路透社报道,多位行业领袖和高管表示,伊朗战争引发了欧洲屋顶太阳能需求的复苏。 由于冲突导致全球石油、天然气和电力价格飙升,家庭和企业都在努力寻找更经济的替代方案,而屋顶太阳能装置已成为关键选择。 德国太阳能设备批发商Solarhandel24的联合创始人雅尼克·诺尔登表示:“这场战争只是暴露了一直存在的问题:能源依赖。”他认为,欧洲各国政府一直以来都在“自投罗网”。 Solarhandel24今年3月的销售额较去年同期增长了两倍,达到近7000万欧元(约合8185万美元),并预计这一销售速度将持续下去。为了满足激增的需求,该公司已将其员工人数增加了三分之一,即85人。 另一家德国可再生能源设备公司Enpal也出现了类似的趋势,3月份订单激增30%,达到1.3亿欧元,预计4月份将增长33%,达到1.2亿欧元,这主要得益于屋顶太阳能装置的销售增长。 Enpal首席执行官马里奥·科勒表示,“这关乎欧洲的韧性”,他还补充说,这种趋势甚至在国防领域也出现了。“正如欧洲必须能够自卫一样,我们也必须能够自给自足地供应能源,”他说道。 对屋顶太阳能日益增长的需求也带动了储能技术的发展,荷兰太阳能公司(Holland Solar)的维南德·范霍夫表示,其销售额增长了40%至50%。 欧洲最大的能源网络运营商E.ON的首席执行官菲利普·托恩表示,“这不能仅仅用季节性因素来解释”,并指出,客户对该公司屋顶太阳能装置的需求与去年同期相比有所增长。高管们还强调了德国可再生能源法在刺激需求方面发挥的作用,并指出2025年新增太阳能装机速度有所放缓。 上述公司尚未回复的置评请求。 (市场动态新闻来源于与全球市场专业人士的对话。这些信息被认为来自可靠来源,但可能包含传闻和推测。准确性无法保证。)
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.